Document Detail

Thrombolytic therapy in infants and children.
MedLine Citation:
PMID:  8122615     Owner:  NLM     Status:  MEDLINE    
Thrombolytic therapy is being increasingly used to treat various cardiac and other disorders in the pediatric population. The use of thrombolytic therapy in thrombosis following cardiac catheterization, aortic thrombosis, right atrial and caval thrombosis, pulmonary embolism, thrombosed prosthetic valves, thrombosed Blalock-Taussig shunts, and other disorders is delineated. Special issues of the newborn are discussed. A wider appreciation of the indications and contemporary experience would help in optimizing the use of thrombolytic therapy in children.
S S Kothari; S Varma; H S Wasir
Related Documents :
18661765 - Doppler myocardial performance index in assessment of ventricular function in children ...
20556725 - Pediatric tracheotomy in special populations: comparison of operative times and survival.
18692635 - Cardiac surgery in adults performed at children's hospitals: trends and outcomes.
23717595 - Intestinal microbiota in healthy u.s. young children and adults--a high throughput micr...
15973525 - Indirect voiding urosonography for detecting vesicoureteral reflux in children.
10479945 - Assessment of anxiety disorders in asthmatic children.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American heart journal     Volume:  127     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-04-05     Completed Date:  1994-04-05     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  651-7     Citation Subset:  AIM; IM    
Department of Cardiology, All India Institute of Medical Sciences, New Delhi.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Infant, Newborn
Plasminogen Activators / therapeutic use
Recombinant Proteins / therapeutic use
Streptokinase / therapeutic use
Thrombolytic Therapy / methods*
Thrombosis / drug therapy,  etiology
Urokinase-Type Plasminogen Activator / therapeutic use
Reg. No./Substance:
0/Recombinant Proteins; EC 3.4.-/Streptokinase; EC 3.4.21.-/Plasminogen Activators; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty.
Next Document:  Solid-angle theory and heart rate adjustment of ST-segment depression for the identification and qua...